How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day

Coronavirus drug in 6 months after producing API

News: Mumbai-based drug major Cipla, credited with several innovations especially in respiratory and flu therapy, could well become one of the first domestic companies to roll out new drugs for the coronavirus. The company is both fast-tracking development of these drugs with government laboratories, and repurposing its wide portfolio of respiratory, asthma, anti-virals and HIV drugs to meet challenges arising from Covid-19 in India.

#InhalersHainSahi

Every year, through our #Breathefree initiative we reach out to over 2mn asthmatic patients, helping them to live a #BerokZindagi. We will continue our relentless pursuit until India breathes free.

#Asthma is a condition that needs to be managed properly with the help of an #inhaler. Watch as Radhika Apte, Chef Vikas Khanna, Parupalli Kashyap and Srishti tell you exactly why asthma ke liye #InhalersHainSahi.

How Cipla Is Embedding Digital Into Its Business Planning And Execution

Cipla is the third largest pharma company in India, an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai. The company is primarily into developing medicines to treat respiratory disorders, cardiovascular diseases, arthritis, diabetes, weight disorders, depression and other medical conditions.